Article

ForbesForbes on 2021-09-24 13:30

What’s Next For Natera Stock After A 14% Rise In A Month?

The stock price of Natera, a clinical genetic testing company, has seen a 14% rise over the last twenty-one trading days, while it is up 30% ...

Related news